• Neuralstem Inc., of Rockville, Md., was issued a U.S. Patent notice of allowance for application No. 12/404,841, for a method that uses expanded spinal cord stem cells, including NSI-566 stem cells, for the treatment of amyotrophic lateral sclerosis, or Lou Gehrig's disease.